期刊文献+

凝血纤溶指标在卵巢过度刺激综合征中的临床应用分析 被引量:5

Clinical application of coagulation fibrinolysis index in patient with ovarian hyperstimulation syndrome
下载PDF
导出
摘要 目的探讨凝血纤溶指标在卵巢过度刺激综合征(OHSS)患者中的改变,为临床治疗提供依据。方法选取64例接受体外受精-胚胎移植(IVF-ET)治疗后发生OHSS患者和40例同期治疗未发生OHSS患者作为对照,收集血浆检测血浆凝血酶原时间(PT)、活化部分凝血活酶时间(APTT)、凝血酶时间(TT)、纤维蛋白原(FIB)和D-二聚体水平,采用t检验分析OHSS患者与对照者凝血纤溶指标的差异,以及治疗前后血浆FIB和D-二聚体活性差异。结果 OHSS患者与对照组比较,PT和TT时间延长,APTT时间缩短,均在正常参考范围内。FIB和D-二聚体含量增高,与对照组比较差异有统计学意义(P<0.05)。OHSS患者治疗后血浆FIB和D-二聚体水平较治疗前下降,差异有统计学意义(P<0.05)。结论血浆凝血纤溶指标用于评估OHSS患者的凝血功能,为临床治疗及预后判断提供重要依据。 Objective To investigate coagulation fibrinolysis index in the patients with ovarian hyperstimulation syndrome(OHSS),and to explore the clinical value.Methods 64 patients undergoing invitro fertilization and embryo transferb(IVF-ET) were developed OHSS and 40 patients as control group who didn′t undergoing OHSS in the same period were analyzed.Plasma samples were collected,and the levels of plasma PT,APTT,TT,FIB and D-dimer were measured and analyzed by t test.Results Compared with control group,PT and TT were longer,but APTT was shorten.Their levels were lied in the reference limit.The levels of FIB and D-dimer of the OHSS patients were higher than control group(P&lt;0.05),but their levels were decreased after the treatment(P&lt;0.05).Conclusion Evaluation of the blood coagulation and fibrinolysis function may be important for predicting prognosis and therapeutic effect for OHSS patients.
出处 《国际检验医学杂志》 CAS 2013年第10期1219-1220,共2页 International Journal of Laboratory Medicine
基金 南京市医学科技发展资金资助项目(QYK11163)
关键词 血栓形成 纤维蛋白纤维蛋白原降解物 卵巢过度刺激综合征 thrombosis fibrin fibrinogen degradation products ovarian hyperstimulation syndrome
  • 相关文献

参考文献10

  • 1Zivi E, Simon A, Laufer N. Ovarian hyperst irnulation syndrome: definition, incidence, and classification[J]. Semin Reprod Med , 2010,28(6):441-447.
  • 2Golan A, Ronel R, Herman A, et a1. Ovarian hyper stimulation syndromej an update review[J]. Obstet Gynecol Surv , 1989,44 (6) :430-440.
  • 3AvecillasJF, Falcone T, Arroliga AC. Ovarian hyperst imulation syndrome[J]. Crit Care Clin,2004,20(4) :679-695.
  • 4Cerrillo M,Pacheco A,Rodriguez Sv et a1. Effect of GnRH agonist and hCG treatment on VEGF, angiopoietin-2, and VE-cadherin: trying to explain the link to ovarian hyperstimulation syndrome[J]. Fertil Steril,2011,95(27) :2517-2519.
  • 5Delvigne A,Rozenberg S. Review of clinical course and treatment of ovarian hyperstimulation syndrome (OHSS)[J]. Hum Reprod Update,2003,9(l) :77-96.
  • 6Chan WS,Dixon ME. The "ART" of thromboembolism: a review of assisted reproductive technology and thromboembolic cornplica?tions[J]. Thromb Res,2008, 121(6) :713-726.
  • 7Westerlund E,Henriksson P, Wallen Hv et a1. Detection of a pro?coagulable state during controlled ovarian hyperstimulation for in vitro fertilization with global assays of haemostasis[J]. Thromb Res,2012.130(4):649-653.
  • 8Fleming T, Sacks G. Nasse[J. Interna[Jugular vein thrombosis following ovarian hyperst irnulation syndrorne]]]. Aust N ZJ Ob?stet Gynaeco1,2012,52(1) :87-00.
  • 9Lippi G. Cervellin G, Franchini M. et al. Biochemical mur kcr s[or the diagnosis of venous thromboembolism: the past. present and future[J].J 'Ihromb Tbrcmbolysis .Eu l Ov Sot t ) :459-471.
  • 10Endo Tv Kirajima Yv Hayashi Tv et a1. Low molecular-weight dex?tran infusion is more effective for the treatment of hemoconcen?tration due to severe ovarian hyperstimulation syndrome than hu?man albumin infusion[J]. Fertil Steril , 2004,82 (5) : 1449-1451.

同被引文献58

引证文献5

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部